Arizona State Retirement System’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$252K Sell
18,099
-4,815
-21% -$67.7K ﹤0.01% 1806
2025
Q4
$277K Buy
+22,914
New +$311K ﹤0.01% 1789
2024
Q2
Sell
-12,061
Closed -$34.3K 2105
2024
Q1
$34.3K Buy
12,061
+759
+7% +$9.93K ﹤0.01% 2122
2023
Q4
$166K Buy
+11,302
New +$173K ﹤0.01% 2008

Other funds holding AMLX

Arizona State Retirement System's AMLX Position: Q1 2026 in Review

Arizona State Retirement System reduced its Amylyx Pharmaceuticals (AMLX) stake by 21% in Q1 2026, selling an estimated $67.7K and leaving 18,099 shares worth $252K. The position accounts for ﹤0.01% of the portfolio, ranked #1806.

Arizona State Retirement System first reported a position in AMLX in Q4 2023 and has held it in 4 quarters since. The position peaked at $277K in Q4 2025. 171 funds tracked by Wall St. Rank hold AMLX as of Q1 2026.

  • Arizona State Retirement System held 18,099 shares of Amylyx Pharmaceuticals worth $252K as of Q1 2026.
  • Arizona State Retirement System sold 4,815 Amylyx Pharmaceuticals shares in Q1 2026, an estimated $67.7K.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Arizona State Retirement System's portfolio in Q1 2026, its #1806 holding.
  • Arizona State Retirement System first reported a position in Amylyx Pharmaceuticals in Q4 2023 and has held it in 4 quarters since.
  • Arizona State Retirement System's Amylyx Pharmaceuticals position peaked at $277K in Q4 2025.
  • 171 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q1 2026.

Based on Arizona State Retirement System's 13F filing for Q1 2026, filed 1 May 2026.